Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2022

Feb 14, 2023

SELL
$48.76 - $77.67 $4.33 Million - $6.9 Million
-88,877 Reduced 93.92%
5,753 $293,000
Q3 2022

Nov 14, 2022

BUY
$61.42 - $86.29 $3.57 Million - $5.02 Million
58,200 Added 159.76%
94,630 $6.66 Million
Q1 2022

May 16, 2022

BUY
$24.28 - $56.64 $884,520 - $2.06 Million
36,430 New
36,430 $2.02 Million
Q4 2020

Feb 16, 2021

SELL
$10.75 - $14.91 $461,809 - $640,518
-42,959 Closed
0 $0
Q3 2020

Nov 16, 2020

BUY
$11.98 - $16.34 $514,648 - $701,950
42,959 New
42,959 $544,000

Others Institutions Holding LNTH

About Lantheus Holdings, Inc.


  • Ticker LNTH
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 68,741,904
  • Market Cap $6.08B
  • Description
  • Lantheus Holdings, Inc. develops, manufactures, and commercializes diagnostic and therapeutic products that assist clinicians in the diagnosis and treatment of heart, cancer, and other diseases worldwide. It provides DEFINITY, a microbubble ultrasound enhancing agent used in ultrasound exams of the heart; TechneLite, a technetium generator for n...
More about LNTH
Track This Portfolio

Track Susquehanna Fundamental Investments, LLC Portfolio

Follow Susquehanna Fundamental Investments, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Susquehanna Fundamental Investments, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Susquehanna Fundamental Investments, LLC with notifications on news.